Marshall & Sterling Wealth Advisors Inc. Astrazeneca PLC Transaction History
Marshall & Sterling Wealth Advisors Inc.
- $148 Billion
- Q2 2025
A detailed history of Marshall & Sterling Wealth Advisors Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Marshall & Sterling Wealth Advisors Inc. holds 35 shares of AZN stock, worth $2,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 76
53.95%
Holding current value
$2,960
Previous $5.55 Million
55.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,459Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.66 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.64 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...